Direct Transfer of p65 into T Lymphocytes from Systemic Lupus Erythematosus Patients Leads to Increased Levels of Interleukin-2 Promoter Activity
- 31 May 2002
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 103 (2), 145-153
- https://doi.org/10.1006/clim.2002.5192
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene deliveryGene Therapy, 2000
- Gene therapy in the treatment of autoimmune diseasesJCI Insight, 2000
- Searching for significance in TCR–cytoskeleton interactionsImmunology Today, 2000
- Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-β1 gene therapy using attenuated Salmonella typhimurium as gene carrierLupus, 1999
- Interleukin-2 and systemic lupus erythematosus—fifteen years laterLupus, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13European Journal of Immunology, 1996
- Transcriptional Regulation of the Interleukin-2 Gene in Normal Human Peripheral Blood T CellsPublished by Elsevier BV ,1996
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte.JCI Insight, 1983